netFormulary Leeds Formulary NHS
Leeds Teaching Hospitals NHS Trust
Leeds and York Partnership NHS Foundation Trust
Leeds Community Healthcare NHS Trust
NHS Leeds CCG
 
 Search
 Formulary Chapter 24: Leeds Children's Hospital Formulary - Full Chapter
Notes:

The Leeds Children's Hospital Formulary is laid out in BNF chapter order. There are custom indexes for the following specialist areas:

Paediatric Intensive Care Unit (PICU)
Neonatal Intensive Care Unit (NICU)
Paediatric Cardiology

Chapter Links...
 Details...
24.01  Expand sub section  Gastro-intestinal system (paediatric)
 note  The neonatal formulary has moved here
Azathioprine
(paediatrics)
View SPC online View childrens BNF
Formulary
Amber 3
 
Link  Amber guidance for IBD and rheumatology in children (azathioprine)
Link  Azathioprine PIL for IBD
Link  Azathioprine: patient information leaflet - children and young people with rheumatological conditions
Link  Azathioprine-Mercaptopurine PIL for IBD
   
Balsalazide
(paediatrics)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Budesonide
(paediatrics)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Erythromycin
( paediatrics)
View adult BNF View SPC online View childrens BNF
Formulary  
Link  Leeds Cystic Fibrosis guidelines: gastric stasis only
   
Esomeprazole
(paediatrics)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
  • Injection only
 
Link  Paediatric intravenous prescribing and administration monograph - esomeprazole
   
Gaviscon Infant
( )
View adult BNF View SPC online
Formulary
Green
 
   
Glycopyrronium Bromide (Glycopyrrolate) (e.g. Robinul, Sialanar)
(paediatrics)
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
  • For hyperhidrosis in children, dermatology and vascular patients (unlicensed use)
  • For drooling and hypersalivation in children with a neurological disorder
  • Glycopyrronium oral solution (licensed) and tablets (unlicensed) supported for the management of drooling and hypersalivation in children
 
Link  Amber Guidance: Glycopyrronium for Hypersalivation in Children and adults
Link  Paediatric Prescribing and Administration Guideline (glycopyrronium)
   
Hyoscine butylbromide
(paediatrics)
View SPC online View childrens BNF
Formulary  
Link  LTHT Medication Safety Alert (June 17) - patients with underlying cardiac disease - practical guidance
Link  MHRA Drug Safety Update (Feb 17): risk of serious adverse effects in patients with underlying cardiac disease
Link  National Paediatric IV Administration Guide (Medusa) - hyoscine butylbromide
   
Lansoprazole
(paediatrics)
View SPC online View childrens BNF
Formulary  
Link  BNFC dosing (lansoprazole)
Link  Leeds Cystic Fibrosis guidelines
Link  Paediatric Prescribing and Administration guideline (lansoprazole)
   
Mercaptopurine
(paediatrics)
View adult BNF View SPC online View childrens BNF
Formulary
Multiple

Amber3 - IBD

Red - cancer

 
Link  Amber Drug Guidance: Mercaptopurine for IBD
Link  Azathioprine-Mercaptopurine PIL for IBD
Link  Patient information leaflet: mercaptopurine for inflammatory bowel disease in children and young people
Link  UK guidelines: IBD in children
   
Mesalazine
(paediatrics)
View adult BNF View SPC online View childrens BNF
Formulary
Amber 3
 
Link  Amber Drug Guidance: Inflammatory Bowel Disease in Children
Link  Aminosalicylates-5-asas PIL for IBD
Link  Mesalazine Foam Enema PIL for IBD
Link  Mesalazine Liquid Enema PIL for IBD
Link  Mesalazine oral PIL for IBD
Link  Mesalazine suppositories PIL for IBD
Link  UK Guidelines: IBD in children
   
Olsalazine
(paediatrics)
View adult BNF View SPC online View childrens BNF
Formulary  
   
Omeprazole
(paediatrics)
View SPC online View childrens BNF
Formulary
  • Omeprazole liquid preparations are not used at LTHT - use omeprazole MUPS
  • IV - use esomeprazole (see above for monograph) 
  • Link  BNFC dosing (omeprazole)
    Link  Leeds Cystic Fibrosis guidelines
    Link  omeprazole dispersible tablets preferred to unlicensed liquid
       
    Ranitidine
    (paediatrics)
    View SPC online View childrens BNF
    Formulary  
    Link  BNFC dosing (ranitidine)
    Link  Leeds Cystic Fibrosis guidelines: adults and children
       
    Sulfasalazine
    (paediatrics)
    View adult BNF View SPC online View childrens BNF
    Formulary  
       
    Ursodeoxychloic acid
    ( paediatrics)
    View adult BNF View SPC online View childrens BNF
    Formulary  
    Link  Leeds Cystic Fibrosis guidelines (adults and children)
       
    Vedolizumab
    ( paediatrics)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
    • For use in line with NICE TA 342 and TA 352 (under the  NHSE Children's Policy)
    • For use in pre-pubertal children, refer to the DTG application (Dec 19) 
     
       
     ....
     Non Formulary Items
    Colief

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
    • Not commissioned for use in the Leeds Health Economy
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Green

    Medicines which are appropriate for initiation and ongoing prescribing in both primary and secondary care.  

    Amber 1

    Amber Level 1- Specialist Recommendation
    These medicines are considered suitable for GP prescribing following specialist recommendation.

    There is no requirement for full Amber Drug Guidance. Generic Amber Level 1 Drug Guidance detailing responsibilities and information sources is available here
      

    Amber 2

    Amber Level 2- Specialist Initiation but no monitoring requirements
    These medicines are considered suitable for GP prescribing following specialist initiation, including titration of dose and assessment of efficacy.
    Some Amber Level 2 products will have an associated Amber Level 2 Drug Guidance document, available by clicking on the traffic light symbol to the right of the drug name. If this is not available, generic Amber Level 2 Drug Guidance is available here  

    Amber 3

    Amber Level 3- Specialist Initiation with ongoing monitoring requirements (Full Amber Drug Guidance required)
    Medicines that should be initiated by a specialist, and which require significant monitoring on an ongoing basis. Full agreement to share the care of each specific patient must be reached under the amber drug agreement, and Amber Drug Guidance must be provided to the GP (available by clicking on the traffic light symbol to the right of the drug name).   

    Red

    Guidance on the responsibilities for Red Drugs can be found here. Red Drugs would usually by prescribed by the hospital for the duration of the course. Primary care prescriber initiation or continuation of treatment not recommended except by Specialist GP and community paediatric prescribing.   

    Grey

    Grey Drugs are locally-agreed medicines which are only recommended for restricted use within the Leeds Health Economy.   

    Black

    These drugs are not recommended for use within the Leeds Health Economy  

    Multiple

    Products shown as blue have different Traffic Light List classifications dependent on indication. See the accompanying text next to the product for further information the indications for which it has a Traffic Light List classification.  

    netFormulary